Merus Labs Report issue

For profit Phase 1 Phase 2
Founded: Vancouver Canada (2011)
Status: Acquired by Norgine (2017)

Organization Overview

First Clinical Trial
2015
NCT02912949
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Merus N.V.